# SS Innovations International, Inc. (SSII)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/ss-innovations-international-inc/ JSON: https://steadybase.io/company/ss-innovations-international-inc.json Checked Nov 10, 2026. Latest filing read: Aug 13, 2026.

## Company

- Legal name: SS Innovations International, Inc.
- Ticker: SSII (Nasdaq)
- SEC CIK: 0001676163
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: Gurugram
- Fiscal year ends: December 31
- SEC filer category: Non-accelerated filer<br>Smaller reporting company
- Website: ssinnovations.com
- Investor relations: https://ssinnovations.com/investors_v2/
- LinkedIn: https://www.linkedin.com/company/ssinnovationsgroup
- Next earnings date: Nov 10, 2026

## Key facts

- Revenue: $42.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/0001213900-26-025440-index.html
- Operating income: -$8.2M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/0001213900-26-025440-index.html
- Net income: -$12.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/0001213900-26-025440-index.html
- SG&A: $14.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/0001213900-26-025440-index.html
- Employees: 483 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea0277925-10k_ssinnova.htm
- Shares outstanding: 200,385,435 as of Aug 12, 2026 (10-Q filed Aug 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026088721/0001213900-26-088721-index.html
- Auditor: Bdo India Services Private Limited, Gurugram, India, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea0277925-10k_ssinnova.htm

## Business

We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “SSi Mantra”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea0277925-10k_ssinnova.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $42.5M | -$8.2M | -$12.1M | $14.8M |
| Dec 31, 2024 | $20.6M | -$19.0M | -$19.2M | $10.2M |
| Dec 31, 2023 | $5.9M | -$20.3M | -$20.9M | $10.1M |
| Dec 31, 2022 | $1.4M | -$3.0M | -$3.2M | $1.9M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/ss-innovations-international-inc.json

## Officers and directors

- Srivastava Sudhir, Chairman and CEO. Source: Form 4 filed Sep 9, 2026, https://www.sec.gov/Archives/edgar/data/1676163/000121390026098544/0001213900-26-098544-index.htm
- Pascual Srivastava Vishwajyoti, CEO - Asia Pacific. Source: Form 4 filed Jun 4, 2026, https://www.sec.gov/Archives/edgar/data/1676163/000121390026065378/0001213900-26-065378-index.htm
- Sarah Romano, CFO. Source: Form 3 filed Aug 4, 2026, https://www.sec.gov/Archives/edgar/data/1676163/000121390026085200/0001213900-26-085200-index.htm
- Milan Rao, Global Chief Operating Officer and Chief Financial Officer. Source: 10-K filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea0277925-10k_ssinnova.htm
- Barry F. Cohen, COO - Americas. Source: Form 4 filed Jun 2, 2026, https://www.sec.gov/Archives/edgar/data/1676163/000121390026064311/0001213900-26-064311-index.htm
- Mylswamy Annadurai, Director. Source: 10-K filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea0277925-10k_ssinnova.htm
- Tim Adams, Director. Source: 10-K filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea0277925-10k_ssinnova.htm

## Recent 8-K events

- Oct 26, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026112292/ea0309597-8k_ssinno.htm
- Oct 13, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026108792/ea0308357-8k_ssinnova.htm
- Oct 13, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026108624/ea0308062-8k_ssinnova.htm
- Oct 5, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026106654/ea0307579-8k_ssinnova.htm
- Sep 10, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026098588/ea0305024-8k_ssinnova.htm
- Aug 26, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026093946/ea0303229-8k_ssinnova.htm
- Aug 13, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026088726/ea0301887-8k_ssinnova.htm
- Jul 17, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026078945/ea0298381-8k_ssinnova.htm
- Jul 14, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026077784/ea0297601-8k_ssinnova.htm
- Jul 7, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026075763/ea0297211-8k_ssinnovation.htm

## Insider trades (Form 4)

- Sep 4, 2026: Srivastava Sudhir (Chairman and CEO) sold 33,333 shares, about $99,999. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026098544/0001213900-26-098544-index.htm
- Mar 6, 2026: Frederic H. Moll (Director) bought 501,253 shares, about $2.0M. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025795/0001213900-26-025795-index.htm
- Mar 6, 2026: Timothy P. Adams (Director) bought 300,000 shares, about $1.2M. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025794/0001213900-26-025794-index.htm
- Mar 6, 2026: Srivastava Sudhir (Chairman and CEO) bought 498,753 shares, about $2.0M. Source: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025793/0001213900-26-025793-index.htm

## Latest filings

- 8-K filed Oct 26, 2026: https://www.sec.gov/Archives/edgar/data/1676163/000121390026112292/ea0309597-8k_ssinno.htm
- 10-K filed Mar 10, 2026: https://www.sec.gov/Archives/edgar/data/1676163/000121390026025440/ea0277925-10k_ssinnova.htm
- 10-Q filed Aug 13, 2026: https://www.sec.gov/Archives/edgar/data/1676163/000121390026088721/ea0299715-10q_ssinnova.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/